ENDO INVESTORS
Endo makes investments in game-changing early stage companies improving outcomes for large patient populations affected by various chronic diseases. Endo is backed by a group of mission-oriented investors and was created in response to a deficit of early-stage capital focused on companies impacting diabetes and other major global health issues.
ENDO INVESTORS
Social Links:
Founded:
2013-01-01
Status:
Active
Technology used in webpage:
Microsoft Exchange Online
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-08-13 | Cecelia Health | Endo Investors investment in Series B - Cecelia Health | 13 M USD |
More informations about "Endo Investors"
Endo Investors – Investing in Life Sciences
Endo is backed by a group of mission-oriented investors and was created in response to a deficit of early-stage capital focused on companies impacting diabetes and other major global health issues. Eric Edidin formed Endo …See details»
Endo Investors - Crunchbase Investor Profile & Investments
Endo makes investments in game-changing early stage companies improving outcomes for large patient populations affected by various chronic diseases. Endo is backed by a group of …See details»
Endo Reports Third-Quarter 2024 Financial Results and Reaffirms …
Nov 5, 2024 Additional information concerning risk factors, including those referenced above, can be found in press releases issued by Endo and in Endo's public filings with the U.S. …See details»
Investors | Endo - Board Committees
Oversees Endo’s legal and fiduciary obligations with respect to matters involving the accounting, auditing, financial reporting, internal control, internal audit, and regulatory compliance …See details»
Endo Investors investment portfolio | PitchBook
Endo Investors General Information Company Description. Founded in 2013, Endo Investors is a venture capital firm based in Los Angeles, California. The firm prefers to invest in the diabetes and healthcare sectors.See details»
Endo Investors - Investments, Portfolio & Company Exits
Aug 13, 2020 Endo Investors 's most notable exits include Bigfoot Biomedical and Capillary Biomedical. Which industries has this organization had the most exits in? Show . Bigfoot …See details»
Press - Endo Investors
Cecelia Health closes $13 million Series B, Rittenhouse’s Saul Richter and Endo Investors’ Eric Edidin to join board of directors, number of members now exceeds 150,000. Read the full …See details»
Endo Investors - LinkedIn
Endo Investors Venture Capital and Private Equity Principals Leading life science investor.See details»
Meet the Team – Endo Investors
Home; About Us; Portfolio Companies; Press; Contact; Meet the TeamSee details»
Investors | Endo - Investor Resources Archive
Investor Resources Archive. The following information pertains to Endo, Inc.’s predecessor company, Endo International plc. Keywords Search. 2023 Q4 Press Release. 2023 Q4 …See details»
Endo to Host Investor Call on Third-Quarter 2024 Financial Results
Oct 15, 2024 Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will release its third-quarter 2024 financial results on November 5, 2024, prior to market open. …See details»
Endo to Host Investor Call on Third-Quarter 2024 Financial Results
Oct 15, 2024 Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will release its third-quarter 2024 financial results on November 5, 2024, prior to market open. …See details»
ENDO Investor Relations - Thermic Science International Corp
Thermic Science International Corp (OTC:ENDO) investor relations materials: earnings calls, slides & pdfs, and letter to shareholders.See details»
Endo, Inc. Completes Acquisition of Endo International plc's Assets
MALVERN, Pa., April 23, 2024 /PRNewswire/ -- Endo, Inc. ("Endo" or the "Company"), a newly formed entity, today announced that it has successfully completed the previously announced …See details»
Endo Pharmaceuticals - Funding, Financials, Valuation & Investors
Endo International plc is a global specialty pharmaceutical company focused on improving patients’ lives while creating value. ... How much funding has this organization raised over …See details»
Endo International Company Profile 2024: Valuation, Investors ...
Dec 13, 2017 Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, …See details»
Investors | Endo - Events & Presentations
May 31, 2024 Browse the calendar to view Investor related events and announcements. Webcasts and presentations that have been archived are available by viewing historical event …See details»
Endo’s 2024 Year in Review
Investors; Careers; Stories; Endo’s 2024 Year in Review; ... In 2024, we proudly fulfilled Endo's vision and mission of empowering everyone we serve to live their best life. As we reflect on …See details»
Endo Launches Doxycycline for Injection, USP - Dec 10, 2024
Dec 10, 2024 Additional information concerning risk factors, including those referenced above, can be found in Endo's press releases and in its public filings with the U.S. Securities and …See details»